severe-asthma

Documents about severe-asthma

• Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air#917777ClinicalTrials.gov
• Asthma In-Home Monitoring (AIM) Trial#892199ClinicalTrials.gov
• Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.#810710ClinicalTrials.gov
• Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma#813771ClinicalTrials.gov
• EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece#1007246ClinicalTrials.gov
• Real Life Experience Survey of Dupilumab in the Netherlands#813451ClinicalTrials.gov
• Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma#913441ClinicalTrials.gov
• Kids 2 Be & Breathe: A Study on the Use of Yoga and Mindfulness in Children With Severe Asthma (K2B2)#914649ClinicalTrials.gov
• Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort#314746Europe PMC
• Preschool Wheeze: Inflammation/Infection Guided Management#826370ClinicalTrials.gov
• Asthma daytime and nighttime symptom diaries: content validity and qualitative exploration of meaningful change in patients with moderate-to-severe asthma.#242112NCBI PubMed Central
• The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma#901996ClinicalTrials.gov
• Success of an oral corticosteroid withdrawal pathway for severe asthma patients on biologics#186572Spiral
• Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects#805900ClinicalTrials.gov
• Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma#852691ClinicalTrials.gov
• Data in support of Inhaled Corticosteroids Influence Pulmonary Microbiota in Severe Equine Asthma#332641Borealis Dataverse OAI Archive
• Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects#825530ClinicalTrials.gov
• A Phase Ib Study of RC1416 Injection#900376ClinicalTrials.gov
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma#801307ClinicalTrials.gov
• A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects#912317ClinicalTrials.gov
• Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics#969237ClinicalTrials.gov
• Assessing the Expression and the Activity of Rac1 Protein in the Airway Smooth Muscle of Asthmatic Patient#811974ClinicalTrials.gov
• Systemic Corticosteroids Avoidance Study in Severe Asthma Patients#854081ClinicalTrials.gov
• Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma#910385ClinicalTrials.gov
• Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).#841328ClinicalTrials.gov
• A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation#840261ClinicalTrials.gov
• Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT#859043ClinicalTrials.gov
• Network Analysis of Severe Asthma in Female Patients to Find Possible Drug Targets.#1001022NCBI PubMed Central
• IL-5 blockade restores the bronchial epithelium and attenuates airway remodelling in severe asthma#475781Europe PMC
• Omalizumab in Severe Asthmatics With Food Allergy#847089ClinicalTrials.gov
• Anti-IL5 and Other Biotherapies in Cystic Fibrosis#896048ClinicalTrials.gov
• A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma#981263ClinicalTrials.gov
• Fungal‐Driven Airways Dis‐Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report#218160HAL (France)
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma#907092ClinicalTrials.gov
• Current understanding and future directions in severe asthma through artificial intelligence-integrated multi-omic approaches.#236003NCBI PubMed Central
• Baseline Composite Score for 12-Month Clinical Remission in Biologic-Treated Severe Asthma: Development of the Base4Score.#140694NCBI PubMed Central
• The Adherence Paradox in Uncontrolled Moderate-To-Severe Asthma: A Qualitative Study of Patient Experiences and Unmet Needs.#645230NCBI PubMed Central
• Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)#839216ClinicalTrials.gov
• Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium#137420HAL (France)
• Predictive Value of Spirometric PIF to Produce PIF Rate Needed for the Use of Current DPI's.#854593ClinicalTrials.gov
• Effectiveness of Anti-IL-5/IL5R Inhibitors#841356ClinicalTrials.gov
• Exploring collaboration preferences of health care professionals and patients regarding treatment decision making in severe asthma: a qualitative study in The Netherlands.#25482NCBI PubMed Central
• Multi-Ancestry Epigenome-Wide Meta-Analysis Identifies Novel Bulk and Cell-Type-Specific Epigenetic Markers of Asthma with Severe Exacerbations#192363bioRxiv / medRxiv
• Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?#785593NCBI PubMed Central
• A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.#913687ClinicalTrials.gov
• Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control#996279eScholarship
• Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study#639874AVESIS
• Efficacy and safety of maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: a randomised controlled trial#649245University of Nottingham Repository
• Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations#1052801eScholarship
• A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma#996357eScholarship